Video Experimental Relacionado
Updated: Jun 20, 2026

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Cánceres de riñón de células claras definidos molecularmente: enfoques prácticos para patólogos quirúrgicos
Mahmut Akgul1,2, Rose S George3, Stephanie E Siegmund1
1Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Abstract:
Molecularly defined renal carcinomas (MDRC) represent a heterogeneous group of tumours characterized by disease-defining genetic alterations, and the documentation of these mutations is necessary for their diagnosis. This group includes TFE3-rearranged renal cell carcinoma (RCC), TFEB-rearranged RCC, TFEB-amplified RCC, fumarate hydratase (FH)-deficient RCC, succinate dehydrogenase (SDH)-deficient RCC, SMARCB1-deficient renal medullary carcinoma (RMC), ALK-rearranged RCC, and ELOC-mutated RCC. Although they account for only about 5% of RCC, they are clinically significant due to distinctive biology, frequent diagnostic pitfalls, and therapeutic implications. Many pathology laboratories lack immediate access to fluorescence in situ hybridization (FISH) or next-generation sequencing (NGS) to confirm MDRC; this review emphasizes morphologic recognition and immunohistochemical surrogates, followed by rational triage for ancillary testing when available.
Más Videos Relacionados
Videos de Conceptos Relacionados
Kidney Structure
Urinary Tract Calculi VI: Surgical Management

